Cargando…
Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides
Non-viral transfection reagents are continuously being developed in attempt to replace viral vectors. Among those non-viral vectors, dendrimers have gained increasing interest due to their unique molecular structure and multivalency. However, more improvements are still needed to achieve higher effi...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831936/ https://www.ncbi.nlm.nih.gov/pubmed/33477663 http://dx.doi.org/10.3390/pharmaceutics13010116 |
_version_ | 1783641725933191168 |
---|---|
author | Daralnakhla, Haneen Saher, Osama Zamolo, Susanna Bazaz, Safa P. Bost, Jeremy Heitz, Marc Lundin, Karin E. EL Andaloussi, Samir Darbre, Tamis Reymond, Jean-Louis Zain, Rula Smith, C. I. Edvard |
author_facet | Daralnakhla, Haneen Saher, Osama Zamolo, Susanna Bazaz, Safa P. Bost, Jeremy Heitz, Marc Lundin, Karin E. EL Andaloussi, Samir Darbre, Tamis Reymond, Jean-Louis Zain, Rula Smith, C. I. Edvard |
author_sort | Daralnakhla, Haneen |
collection | PubMed |
description | Non-viral transfection reagents are continuously being developed in attempt to replace viral vectors. Among those non-viral vectors, dendrimers have gained increasing interest due to their unique molecular structure and multivalency. However, more improvements are still needed to achieve higher efficacy and lower toxicity. In this study, we have examined 18 peptide dendrimers conjugated to lipophilic moieties, such as fatty acids or hydrophobic amino acids, that were previously explored for siRNA. Reporter cells were employed to investigate the transfection of single strand splice-switching oligonucleotides (ONs) using these peptide dendrimers. Luciferase level changes reflecting efficiency varied with amino acid composition, stereochemistry, and complexation media used. 3rd generation peptide dendrimers with D-amino acid configuration were superior to L-form. Lead formulations with 3rd generation, D-amino acid peptide dendrimers increased the correction level of the delivered ON up to 93-fold over untreated HeLa Luc/705 cells with minimal toxicity. To stabilize the formed complexes, Polyvinyl alcohol 18 (PVA18) polymer was added. Although PVA18 addition increased activity, toxicity when using our best candidates G 2,3KL-(Leu)(4) (D) and G 2,3KL-diPalmitamide (D) was observed. Our findings demonstrate the potential of lipid-conjugated, D-amino acid-containing peptide dendrimers to be utilized as an effective and safe delivery vector for splice-switching ONs. |
format | Online Article Text |
id | pubmed-7831936 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78319362021-01-26 Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides Daralnakhla, Haneen Saher, Osama Zamolo, Susanna Bazaz, Safa P. Bost, Jeremy Heitz, Marc Lundin, Karin E. EL Andaloussi, Samir Darbre, Tamis Reymond, Jean-Louis Zain, Rula Smith, C. I. Edvard Pharmaceutics Article Non-viral transfection reagents are continuously being developed in attempt to replace viral vectors. Among those non-viral vectors, dendrimers have gained increasing interest due to their unique molecular structure and multivalency. However, more improvements are still needed to achieve higher efficacy and lower toxicity. In this study, we have examined 18 peptide dendrimers conjugated to lipophilic moieties, such as fatty acids or hydrophobic amino acids, that were previously explored for siRNA. Reporter cells were employed to investigate the transfection of single strand splice-switching oligonucleotides (ONs) using these peptide dendrimers. Luciferase level changes reflecting efficiency varied with amino acid composition, stereochemistry, and complexation media used. 3rd generation peptide dendrimers with D-amino acid configuration were superior to L-form. Lead formulations with 3rd generation, D-amino acid peptide dendrimers increased the correction level of the delivered ON up to 93-fold over untreated HeLa Luc/705 cells with minimal toxicity. To stabilize the formed complexes, Polyvinyl alcohol 18 (PVA18) polymer was added. Although PVA18 addition increased activity, toxicity when using our best candidates G 2,3KL-(Leu)(4) (D) and G 2,3KL-diPalmitamide (D) was observed. Our findings demonstrate the potential of lipid-conjugated, D-amino acid-containing peptide dendrimers to be utilized as an effective and safe delivery vector for splice-switching ONs. MDPI 2021-01-18 /pmc/articles/PMC7831936/ /pubmed/33477663 http://dx.doi.org/10.3390/pharmaceutics13010116 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Daralnakhla, Haneen Saher, Osama Zamolo, Susanna Bazaz, Safa P. Bost, Jeremy Heitz, Marc Lundin, Karin E. EL Andaloussi, Samir Darbre, Tamis Reymond, Jean-Louis Zain, Rula Smith, C. I. Edvard Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides |
title | Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides |
title_full | Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides |
title_fullStr | Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides |
title_full_unstemmed | Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides |
title_short | Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides |
title_sort | lipophilic peptide dendrimers for delivery of splice-switching oligonucleotides |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831936/ https://www.ncbi.nlm.nih.gov/pubmed/33477663 http://dx.doi.org/10.3390/pharmaceutics13010116 |
work_keys_str_mv | AT daralnakhlahaneen lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides AT saherosama lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides AT zamolosusanna lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides AT bazazsafa lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides AT pbostjeremy lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides AT heitzmarc lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides AT lundinkarine lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides AT elandaloussisamir lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides AT darbretamis lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides AT reymondjeanlouis lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides AT zainrula lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides AT smithciedvard lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides |